<DOC>
	<DOCNO>NCT00295789</DOCNO>
	<brief_summary>To evaluate clinical benefit Paclitaxel plus Carboplatin compare Paclitaxel plus Cisplatin Stage IVb , Persistent , Recurrent Cervical Cancer</brief_summary>
	<brief_title>Trial TP Versus TC Regimens Stage IVb , Persistent , Recurrent Cervical Cancer ( JCOG0505 , CC-TPTC-P3 )</brief_title>
	<detailed_description>Prognosis advance , recurrent , persistent cervical cancer , amenable curative treatment surgery and/or radiation therapy , still remain poor . Recently , cisplatin plus paclitaxel palliative chemotherapy report improve response rate progression-free interval compare cisplatin alone show new appropriate regimen . However , effective and/or less toxic combination need . Carboplatin single agent less response rate less overall toxicity cisplatin . Particularly , less nephrotoxicity require hydration less neurotoxicity enable 3hrs administration paclitaxel combination , patient therapy become possible patient ' quality life must improve . Therefore , plan evaluate benefit le toxicity chemotherapy contain paclitaxel carboplatin , could reduce hospitalised day , comparison standard chemotherapy contain paclitaxel cisplatin . This clinical trial target patient Japan incurable cervical cancer diagnose mean image .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>1. histologically proven uterine cervical cancer 2. squamous cell carcinoma , adenocarcinoma , adenosquamous cell carcinoma uterine cervix 3. one following , 1 ) primary stage Ⅳb cervical cancer , 2 ) first relapse persistent cervical cancer curative first line treatment , 3 ) second relapse persistent cervical cancer curative second line treatment include radiation , systemic chemotherapy , hormonal therapy , vaccination therapy first relapse 4 . Patients may previously treat less 50 Gy palliative radiation therapy 5 . Patients receive prior treatment certain interval must elapse last administration previous treatment include palliative radiation therapy 6. one following , 1 ) There least one metastatic lesion outside pelvic cavity except paraaortic LN and/or inguinal LN , 2 ) There metastatic lesion outside pelvic cavity except paraaortic LN and/or inguinal LN lesion irradiate , 3 ) All lesion localize inside pelvic cavity , irradiate 7. prior surgical therapy metastatic lesion lung inside pelvic cavity 8. bilateral hydronephrosis 9. prior chemotherapy include two platinumcontaining regimen 10. prior chemotherapy include taxane 11. age : 20 to75 year 12 . PS : 02 13 . ANC ≧1,500 /mm3 , Plt≧10.0×104/mm3 , Tbil≦1.5 mg/dl , GOT（AST）≦100IU/l , sCre ≦1.2 mg/dl , Ccr≧50ml/min use CockcroftGault equation , normal ECG 14. write informed consent 1. patient neurologically functional disorder 2. symptomatic CNS metastasis 3. hypersensitive alcohol 4. active infection 5 . HBs antigen positive 6. uncontrollable hypertension 7. history myocardiac infarction within six month 8. unstable angina 9. uncontrollable diabetes 10 . Patients concomitant prior invasive malignancy ( except intramucosal malignancy curable local therapy ) evidence disease within last 5 year 11. woman pregnancy breastfeed 12. patient psychiatric illness 13. patient treated systemic steroid medication</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>palliative chemotherapy</keyword>
	<keyword>recurrent</keyword>
	<keyword>persistent</keyword>
	<keyword>stageⅣb</keyword>
	<keyword>cisplatin</keyword>
	<keyword>carboplatin</keyword>
	<keyword>paclitaxel</keyword>
</DOC>